| Financial Year |
September 30 2020 |
| Monetary Funds |
11,335,530,206.07 |
| Held-for-trading Financial Assets |
8,617,414,376.86 |
| Notes Receivable |
509,180.00 |
| Accounts Receivable |
561,547,643.49 |
| Advances to Suppliers |
208,104,739.31 |
| Other Receivables |
189,614,172.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
10,493,286.33 |
| Inventories |
180,554,283.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,765,566,554.31 |
| Total Current Assets |
31,541,495,591.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
103,648,561.31 |
| Investment Properties |
27,029,859.09 |
| Fixed Assetes |
400,577,419.46 |
| Under-construction Projects |
8,525,036.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
57,442,218.31 |
| R&D expenses |
23,153.00 |
| Goodwill |
1,172,821,763.65 |
| Long-Term Deferred and Prepaid Expenses |
16,549,534.49 |
| Deferred Income Tax Assets |
159,168,739.38 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,286,563,698.07 |
| Total Assets |
33,828,059,289.30 |
| Short-Term Loans |
193,541,000.00 |
| Trading Financial liabilities |
39,822,658.06 |
| Notes Payable |
-- |
| Accounts Payable |
16,647,574.15 |
| Accounts Received In Advance |
2,651,319.48 |
| Employee Compensation Payable |
208,572,318.73 |
| Taxes Payable |
106,579,745.63 |
| Interest Payable |
-- |
| Dividend Payable |
1,990,113.13 |
| Other payables |
89,772,386.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,198,567,700.18 |
| Other Current Liabilities |
2,706,593,415.02 |
| Sub-Total of Current Liabilities |
22,588,837,255.53 |
| Long-term Loans |
915,000.00 |
| Bonds Payable |
517,365,368.30 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
11,744,079.64 |
| Deferred Income Tax Liabilities |
36,533,806.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
569,900,096.02 |
| Total Liabilities |
23,158,737,351.55 |
| Paid-In Capital(Or Share Stock) |
2,681,990,294.00 |
| Capital Surplus |
4,861,576,471.47 |
| Surplus Reserve |
364,793,253.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,998,571,118.64 |
| Minority Stockholder's Interest |
56,820,536.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,612,501,401.35 |
| Owner's Equity（Stockholder's Equity） |
10,669,321,937.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
33,828,059,289.30 |
